Show Summary Details
Page of

Deployment Finesse of the Gore Excluder Stent Graft 

Deployment Finesse of the Gore Excluder Stent Graft
Deployment Finesse of the Gore Excluder Stent Graft

S. Lowell Kahn

, and Sergio Rojas

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 17 September 2021

The Gore Excluder stent graft was approved for use in the United States by the US Food and Drug Administration (FDA) in 2002. The Excluder is a modular, bifurcated endoprosthesis utilized in the treatment of abdominal aortic aneurysms. The Excluder endoprosthesis is constructed from an expanded polytetrafluoroethylene film and an incorporated “weldless” nickel–titanium stent skeleton for support. The device features no sutures, infrarenal fixation, and is made to be inserted through 12–18 Fr introducer sheaths. Since its approval by the FDA, the Excluder has undergone multiple changes, including profile reductions, the addition of an impermeable membrane (due to early graft material design associated with type IV endoleaks), and, most notably, a repositioning mechanism labeled the C3 Excluder. This chapter discusses multiple techniques of deployment of the Gore Excluder stent graft.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.